Related Experiment Videos
Summary
Childhood acute lymphoblastic leukemia (cALL) incidence is rising in sub-Saharan Africa, with a poor prognosis. Acute myeloid leukemia (AML) is frequent in male children, and its adult incidence may increase due to environmental factors.
Area of Science:
- Hematology
- Epidemiology
- Oncology
Background:
- Childhood acute lymphoblastic leukemia (cALL) was uncommon in sub-Saharan Africa but now shows a peak incidence in 3-5 year olds in West and Southern Africa.
- Acute myeloid leukemia (AML) has a high incidence in male children (5-14 years), with up to 25% presenting with chloroma.
- Chronic myeloid leukemia (CML) shows no specific epidemiological features but is frequent in young adults and children.
- Two forms of B-cell chronic lymphocytic leukemia (B-CLL) exist: one in women of low socioeconomic status, possibly linked to infections, and another over 45 years, with male predominance.
Purpose of the Study:
- To describe the epidemiological features of various leukemias in sub-Saharan Africa.
- To highlight emerging trends and risk factors for childhood and adult leukemias.
- To discuss the prognostic challenges and potential causes of leukemia in the region.
Main Methods:
- Epidemiological analysis of leukemia incidence and demographics.
- Review of clinical, biological, and social factors affecting prognosis.
- Identification of potential environmental and lifestyle risk factors for adult AML.
Main Results:
- cALL incidence is increasing in sub-Saharan Africa, particularly in young children, with poor outcomes.
- AML is prevalent in young males, and adult incidence may rise due to environmental exposures and treatments.
- B-CLL exhibits distinct epidemiological patterns based on age, sex, and socioeconomic status.
Conclusions:
- Leukemia epidemiology in sub-Saharan Africa is evolving, with specific patterns for cALL, AML, CML, and B-CLL.
- Prognosis for African cALL patients is poor due to multifactorial issues.
- Environmental and lifestyle factors are potential contributors to rising AML incidence in adults.